Trial intelligence / Profile preview

Simvastatin on Subarachnoid Hemorrhage-Induced Vasospasm

NCT00235963Phase 2Completed

Sponsor
Brigham and Women's Hospital
Start
Dec 2002
Primary completion
Jan 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of simvastatin in subarachnoid hemorrhage (SAH), vasospasm, sponsored by Brigham and Women's Hospital. Started Dec 2002; status: completed.

02

Drugs

simvastatin
03

Conditions

subarachnoid hemorrhage (SAH)vasospasm

Beyond the preview

Go deeper on NCT00235963.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00235963.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call